Skip to main content

Advertisement

Fig. 4. | Acta Neuropathologica Communications

Fig. 4.

From: Pediatric low-grade glioma in the era of molecular diagnostics

Fig. 4.

Molecular testing decision tree for pediatric low-grade glioma. *The frequency with which tumors harbor an FGFR1 mutation and additional mutations justifies continued testing regardless of status. AG: angiocentric glioma, DNET: dysembryoplastic neuroepithelial tumour, GNT: glioneuronal tumor, ODG: oligodendroglioma, PA: pilocytic astrocytoma, GG: ganglioglioma, PXA: pleomorphic xanthoastrocytoma, DA: diffuse astrocytoma

Back to article page